当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Jennifer Joel
Background and Objective: Psoriasis is a common immune system infection that often goes hand in hand with other conditions. The purpose of this study was to investigate the prevalence of atrophic mind changes and small vessel cerebrovascular disease (SVCD) on MRIs of healthy people and psoriasis patients.
Materials and Methods: To examine the average global decay (MTA) score, global cortical decay (GCA) score, and Fazekas scale, cerebrum MRI was performed on each individual. Finally, the total frequencies of each boundary between the two groups were considered.
Results: The recurrence of the Fazekas scale, GCA, and MTA scores did not significantly differ between the two groups. However, when compared to the case group, a slight pattern emerged: controls had higher recurrences of Fazekas scale, GCA, and MTA scores. The Fazekas scale had no significant correlation with illness duration (p=0.16), but there was a significant positive correlation (p0.001) between illness duration and GCA and MTA scores. There was no significant connection found between the status of Fazekas, GCA, and MTA and the various boundaries.
Conclusion: In psoriasis patients, separating terms of CNS contribution might be necessary because the increase in sickness duration was primarily accompanied by an increase in the occurrence of cerebral decay.